Skip to main content
F

Fuan Pharmaceutical (Group)co.,Ltd — Investor Relations & Filings

Ticker · 300194 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,009 across all filing types
Latest filing 2024-08-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical (Group)co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于增加闲置自有资金现金管理额度的公告
Regulatory Filings
2024-08-28 Chinese
董事会决议公告
Regulatory Filings
2024-08-28 Chinese
关于子公司通过美国FDA现场检查的公告
Regulatory Filings
2024-08-20 Chinese
关于子公司收到药品补充申请批准通知书的公告
Regulatory Filings
2024-08-07 Chinese
关于子公司收到药品补充申请批准通知书的公告
Regulatory Filings
2024-08-02 Chinese
关于子公司收到药品注册证书的公告
Regulatory Filings
2024-07-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.